Fundraising Fox

elevatebio

Waltham, US · 447 employees on LinkedIn · 4 known investors

ElevateBio is a contract development and manufacturing organization (CDMO) for advanced therapies, offering discovery, process development, analytics, manufacturing, and regulatory support for cell therapies, viral vectors, mRNA therapeutics, and gene editing. It partners with drug developers to bring cell and gene therapies from early discovery through commercial-scale cGMP manufacturing.

BiotechDeep TechHealthtech

Founders & leadership

DH
David HallalCEO
MP
Mike PagliaChief Technology Officer
GB
Ger BrophyCEO

Investors · 4

EcoR1 CapitalSan Francisco
MPM BioImpactBoston · $1M – $15M
Samsara BioCapitalPalo Alto
SoftBank Vision FundLondon

Competitors · 1

by search overlap
AskBio42 shared keywordsAskBio is a gene therapy company developing adeno-associated virus (AAV)-based genetic medicines for rare and other diseases, with clinical programs such as AB-1009 for late-onset Pompe disease. It operates as a wholly owned, independent subsidiary of Bayer AG.

Companies competing with elevatebio for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does elevatebio do?
ElevateBio is a contract development and manufacturing organization (CDMO) for advanced therapies, offering discovery, process development, analytics, manufacturing, and regulatory support for cell therapies, viral vectors, mRNA therapeutics, and gene editing. It partners with drug developers to bring cell and gene therapies from early discovery through commercial-scale cGMP manufacturing.
Who founded elevatebio?
elevatebio was founded by David Hallal.
Who are elevatebio's investors?
elevatebio's investors include EcoR1 Capital, MPM BioImpact, Samsara BioCapital, SoftBank Vision Fund.
Where is elevatebio headquartered?
elevatebio is headquartered in Waltham, US.